CMG at CPHI China: Bringing Tomorrow’s Ingredients to Australia First
Our Managing Director, Craig Fallshaw, recently spent three days at CPHI (Convention on Pharmaceutical Ingredients) China, one of the world’s largest pharmaceutical and nutraceutical ingredient trade shows. The trip has set CMG up with an exciting pipeline of innovation for the year ahead. Representing Australia on the World Stage We were proud to spend time […]
CMG’S Dr Brad Receives Global Excellence Award
A proud moment for everyone at Complementary Medicines Group. Congratulations to our own Dr Brad McEwen PhD on receiving the Global Excellence Award from the Institute of Engineers, Malaysia, in recognition of his outstanding contributions to innovation, product development, and excellence in healthcare and research. Brad’s ability to combine science, innovation, and quality plays a […]
New Product Development (NPD)
New Product Development (NPD): A Landmark Year for Complementary Medicines 2025 marks a pivotal year for the complementary medicines industry, driven by robust new product development (NPD) and sustained industry growth. Currently, the Australian complementary medicines market is valued at an impressive $6.2 billion annually. Consumer engagement is at an all-time high, with approximately 75% of […]
New Product Development (NPD) for 2025
New Product Development (NPD) for 2025 By Dr Brad McEwen PhD, MHSc, MPH, BHSc CMG Head of Products and Innovation 2024 marked a significant period for the industry, characterised by substantial new product development (NPD) and overall industry growth. At present, the Australian complementary medicines industry is valued at an impressive $6.2 billion annually. There […]